Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8229882 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 9 Pages |
Abstract
In anal cancer, when OTT is <80 days, BCT boost is superior to EBRT boost for CRLR. These results suggest investigating the benefit of BCT boost in prospective trials.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jean-Michel M.D., Ph.D., Cécile M.D., Michel M.D., Eric M.D., Philippe M.D., Didier M.D., Audrey M.D., Karen M.D., Eric M.D., Naji M.D., Steve M.D., David M.D., Ph.D., Jean-Pierre M.D.,